Crossmark

Design, synthesis, molecular dynamics and in silico pharmacokinetic study of N-(4-(thiazol-2-ylamino)phenyl)benzamide analogues as promising anti-inflammatory agents

Crossref DOI link: https://doi.org/10.1007/s11696-025-04535-1

Published Online: 2025-12-08

Published Print: 2026-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kashyap, Manoj https://orcid.org/0000-0002-9675-8646
Mazumder, Muslek Uddin https://orcid.org/0000-0002-1540-3086
Patowary, Pooja https://orcid.org/0000-0002-0476-2868
Hruaitluangi, Lalnun https://orcid.org/0009-0005-9268-7317
Sailo, Lalzikpuii https://orcid.org/0009-0006-5985-3501
Deka, Babita https://orcid.org/0000-0002-9920-6708
Dasgupta, Debaprotim https://orcid.org/0000-0002-7164-7472
Talukdar, Apurba https://orcid.org/0000-0001-9538-2512
Sahariah, Bhargab Jyoti https://orcid.org/0000-0003-0440-6983
License Information

Text and Data Mining valid from 2025-12-08

Version of Record valid from 2025-12-08
More Information

Article History

Received: 19 June 2025

Accepted: 18 November 2025

First Online: 8 December 2025

Declarations

:

: The authors have no relevant conflicts of interest to declare that are relevant to the content of this article.

: The study was approved by the Institutional Animal Ethics Committee, NETES Institute of Pharmaceutical Science, Assam, India (Approval No.: NIPS/AH/24/023 dated. 10-02-2024). Acute oral toxicity study was carried out as per the OECD 425 guidelines.

: Not applicable.

Document is current

Any future updates will be listed below